Full human antibody derived from human primary B cells is constrained by low affinity, limited availability of human samples, sometime ethic problems; humanized mouse strain carrying human germline VDJ region is of great alternative for generation of full human antibody, which devoid of potential immunogenic issues as mouse monoclonal antibody. iCareab now lunch full human antibody development service in combination of humanized mouse and traditional hybridoma technique.